Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02154880 · ClinicalTrials.gov registry record
Translation Evaluation of Aging, Inflammation and HIV in Lung Function (TEAL)
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 323
- Enrollment target
NCT02154880: Completed study, sponsored by University of Pittsburgh.
NCT02154880 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 323 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02154880 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 323 participants
- Enrollment target
Study Summary
Hypothesis;Aging modifies the risk of pulmonary dysfunction in HIV+ individuals. The study is a multicenter, prospective observational study of aging and pulmonary function in HIV. The investigator will determine the prevalence and risk factors for lung dysfunction as quantified by pulmonary function testing in both younger (\<50 years) and older (≥50 years) HIV+ and HIV-uninfected controls. The investigator will build on existing cohorts and enrich enrollment for individuals over the age of 50 while adjusting for important co-variates such as ART, smoking history, co-infections, and illicit drug use. Evaluations will be scheduled at baseline, 18 months, and 36 months. Study visits will consist of blood draw, questionnaires, and pulmonary function testing.
Primary Outcome
determine the prevalence and risk factors for lung dysfunction as quantified by pulmonary function testing in both younger (\<50 years) and older (≥50 years) HIV+ and HIV-uninfected controls. We will build on existing cohorts and enrich enrollment for individuals over the age of 50 while adjusting for important co-variates such as ART, smoking history, co-infections, and illicit drug use.
Interventions
- PROCEDURE PFT
- OTHER questionnaires
- PROCEDURE lab work
- PROCEDURE 6MWT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 323 participants |
| Start Date | 2014-02 |
| Est. Completion | 2020-03-02 |
What the finished NCT02154880 record still lists
NCT02154880 is an observational study that tracks outcomes without assigning an intervention. The registered 323 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 4 interventions - of which PFT is the first listed.
NCT02154880 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02154880 about?
NCT02154880 is a clinical study titled "Translation Evaluation of Aging, Inflammation and HIV in Lung Function (TEAL)". Hypothesis;Aging modifies the risk of pulmonary dysfunction in HIV+ individuals. The study is a multicenter, prospective observational study of aging and pulmonary function in HIV. The investigator will determine the prevalence and risk factors for lung dysfunction as quantified by pulmonary functi...
What is the current status of trial NCT02154880?
This trial is currently completed. The enrollment target is 323 participants. The study started on 2014-02. Estimated completion is 2020-03-02.
What interventions are being tested in trial NCT02154880?
The interventions under investigation include: PFT (PROCEDURE), questionnaires (OTHER), lab work (PROCEDURE), 6MWT (PROCEDURE).
Who is sponsoring clinical trial NCT02154880?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04164173 · 324 participants · NA
Hyperinflation Respiratory Therapies in Cardiac Surgery Patients
- NCT04708054 · 324 participants · Phase 2
Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS
- NCT05261399 · 324 participants · Phase 3
Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment
- NCT05353322 · 324 participants · NA
Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia